Hormonal
Repeated exercise training produces persistent improvements in skeletal muscle insulin sensitivity through up-regulation of GLUT4, AMPK, and lipid oxidation pathways, whereas a single bout of exercise only provides a transient (approx. 48h) insulin-sensitizing effect.
To fix insulin resistance, you need to train consistently, not just occasionally. While one workout helps for a day or two, only regular exercise builds the lasting muscle adaptations (like more GLUT4 and better fat burning) that keep your blood sugar stable long-term. Focus on building a routine rather than chasing a single 'perfect' session.
In contrast, repeated physical activity (i.e. exercise training) results in a persistent increase in insulin action in skeletal muscle from obese and insulin-resistant individuals... However, this 'insulin sensitizing' effect is short-lived and disappears after ~48 h.
Why this rating
This is a review paper citing multiple human and rodent studies showing consistent trends, though specific quantitative meta-analytic data is not the primary focus of this specific text.
Source
Exercise training‐induced improvements in insulin action
John A. Hawley et al. · Acta Physiologica · 2007
DOI 10.1111/j.1748-1716.2007.01783.x
More from this paper
- Exercise training improves insulin sensitivity in insulin-resistant individuals by increasing lipid oxidation and reducing intramuscular lipid species (ceramides and diacylglycerol) that inhibit insulin signaling.Good
- Exercise training restores impaired insulin-stimulated PI3-kinase (PI3K) activity in skeletal muscle, which is typically decreased in insulin-resistant subjects and type 2 diabetes patients.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →